secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2026-05-18T13:11:42+00:00
Accession:  0001193125-26-228031
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty amends merger agreement to add newly formed holding company for Ligand acquisition
--------------------------------------------------------------------------------

- HoldCo (XOMA Royalty Holdings Corporation) formed on May 15, 2026 and added as party to the Merger Agreement with Ligand Pharmaceuticals.
- Amendment No. 1, dated May 16, 2026, among XOMA Royalty, HoldCo, Ligand, and Merger Sub, facilitates the holding company reorganization.
- HoldCo will survive the merger as a wholly owned subsidiary of Ligand; references in the Merger Agreement are updated accordingly.
- Changes include replacing 'Company' with 'Surviving Corporation' in Sections 1.5 and 5.23, and updating the NRS statutory reference.
- Overall terms of the Merger Agreement remain unchanged; the amendment is procedural for the previously announced acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312526228031/0001193125-26-228031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312526228031/d130820d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-228031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer